搜索筛选:
搜索耗时2.5106秒,为你在为你在102,285,761篇论文里面共找到 16 篇相符的论文内容
类      型:
[会议论文] 作者:Xiao Ding,Jiuwei Cui, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:Guozi Yang,Jiuwei Cui,Jiuwei Cui,Lihua Dong,Zhenyu Pan, 来源:第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份:2015
Objective: Low-dose radiation (LDR) has been proposed to induce an adaptive response in normal cells but not in tumor cells, which may protect normal tissue against the damage of conventional radiatio...
[期刊论文] 作者:Hanfei Guo,Lingyu Li,Jiuwei Cui, 来源:中国癌症研究(英文版) 年份:2020
Small cell lung cancer (SCLC) is a highly lethal disease,characterized by early metastasis and rapid growth,and no effective treatment after relapse.Etoposide-p...
[会议论文] 作者:Ling Bai,Jiuwei Cui,Wei Li, 来源:2019中国肿瘤学大会 年份:2019
[期刊论文] 作者:Hanfei Guo,Lei Qian,Jiuwei Cui, 来源:癌症生物学与医学(英文版) 年份:2022
Cytokine release syndrome (CRS) is a major obstacle to the widespread clinical application of chimeric antigen receptor (CAR) T cell therapies. CRS can also be induced by infections (such as SARS-CoV-2), drugs (such as therapeutic antibodie......
[期刊论文] 作者:Rilan Bai,Wenqian Li,Nawen Du,Jiuwei Cui, 来源:中国癌症研究(英文版) 年份:2019
Immunotherapy is one of the most promising treatments for multiple tumor types.The significant clinical benefits and durable responses of immunotherapy have led...
[期刊论文] 作者:Hanfei Guo,Wenqian Li,Lei Qian,Jiuwei Cui, 来源:中国癌症研究:英文版 年份:2021
Immune checkpoint inhibitors(ICIs),a type of immunotherapy,have become one of the most important therapeutic options for first-and second-line treatment of adva...
[会议论文] 作者:Guozi Yang,Lihua Dong,Zhenyu Pan,Jiuwei Cui, 来源:第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份:2015
  Objective: Low-dose radiation (LDR) has been proposed to induce an adaptive response in normal cells but not in tumor cells, which may protect normal tissue...
[期刊论文] 作者:Hanfei Guo,Wenqian Li,Bin Wang,Neifei Chen,Lei Qian,Jiuwei Cui, 来源:中国癌症研究(英文版) 年份:2021
Curative therapy was not previously available for patients with advanced non-small cell lung cancer (NSCLC);thus,the concept of minimal/measurable (or molecular) residual disease (MRD) was not applicable to these patients.However,advances i......
[期刊论文] 作者:Rilan Bai,Lingyu Li,Xiao Chen,Yuguang Zhao,Wei Song,Huimin Tian,Jiuwei Cui, 来源:中国癌症研究:英文版 年份:2021
Small cell lung cancer(SCLC)is a high-grade neuroendocrine(NE)cancer characterized by high circulating tumor-cell burden and early extensive metastasis.Considering the complexity of SCLC genes and the immune microenvironment,their unique mo......
[会议论文] 作者:Jifan Hu,Wei Li,Jiuwei Cui,Guanjun Wang,Andrew R.Hoffman,Hong Wang,Jingnan Sun, 来源:2013首届世界健康大会 年份:2013
Although induced pluripotent stem cells (iPSCs) can be reprogrammed from human somatic cells using four defined factors, the process is extremely inefficient, as there is a strong epigenetic block pre...
[会议论文] 作者:Ling Bai,Jiuwei Cui,Wei Chen,Wei Li,Lei Zhou,Chao Niu,Jingtao Chen,Wei Han, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:Ling Bai,Wei Chen,Wei Li,Lei Zhou,JIngtao Chen,Wei Han,Chao Niu,Jiuwei Cui, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:yizhuo wang,Huijie Xiao,Chang Wang,Haitao Wu,Hua He,Cheng Yao,Wei Li,Jiuwei Cui, 来源:2019中国肿瘤学大会 年份:2019
Objective Gastric cancer is the fifth most frequently diagnosed cancer and the thirdleading cause of cancer-related mortality.Advances in the treatment of gastric cancer have included the establishmen...
[会议论文] 作者:Wenqian Li,Rilan Bai,Lei Qian,Naifei Chen,Yuguang Zhao,Fujun Han,Ling Bai,Jiaxuan Li,Yu Yu,Jiuwei Cui, 来源:2019中国肿瘤学大会 年份:2019
Objective Lung cancer has been the leading cause of cancer death,among which approximately 80%is non-small cell lung cancer(NSCLC),besides,NSCLC patients with brain metastases had a poor prognosis.Mor...
[期刊论文] 作者:,Naifei Chen,Xiao Chen,Lingyu Li,Wei Song,Wei Li,Yuguang Zhao,Yongfei Zhang,Fujun Han,Zheng Lyu,Jiuwei Cui, 来源:癌症生物学与医学(英文版) 年份:2021
Objective: We aimed to retrospectively analyze the toxicity profiles and predictors of immune-related adverse events (irAEs) as well as the correlation between irAEs and the clinical efficacy of multi-type immune checkpoint inhibitors (ICIs......
相关搜索: